ArticleInternational journal of women's health2026
Random Survival Forest Model for Predicting Recurrence of Postoperative Ovarian Endometrioma.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and compare a random survival forest (RSF) model and a Cox regression model-for predicting postoperative recurrence in patients with ovarian endometrioma. Methods: The primary outcomes of the study were the recurrence of ovarian endometrioma and the time to recurrence. Recurrence-related clinical variables were assessed using two methods: Cox regression analysis and the random survival forest algorithm. The performance of the prediction models was evaluated using time dependent Receiver Operating Characteristic (time-dependent ROC) curve, calibration curve, and Decision Curve Analysis (DCA) curve. Results: 109 patients experienced recurrence of postoperative ovarian endometrioma, while 469 patients did not experience recurrence. The multivariate Cox regression model identified four independent variables. The RSF model was constructed using 12 important clinical variables. In the training set, the Cox model presented a lower C-index compared to the RSF model (0.699 vs. 0.987). However, in the testing set, the Cox model had a slightly higher C-index compared to the RSF model (0.771 vs. 0.763). The classification accuracy of the RSF model and the traditional Cox regression model was evaluated using two performance metrics: NRI and IDI. The NRI at 3 years and 5 years were 0.728 and 0.775 respectively. The IDI at 3 years and 5 years were 0.599 and 0.603 respectively. Conclusion: The predictive performance of the RSF model was slightly better than that of the traditional Cox model for predicting postoperative recurrence in patients with ovarian endometrioma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.